Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Shire Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (18)
Australian Public Assessment Report (AusPAR) (8)
Prescription medicine registration (6)

Date

2020 (4)
2019 (6)
2018 (12)
2017 (3)
2014 (2)
2013 (1)
2012 (2)
2010 (2)

Results for "[search-keyword]"

Search

Sponsor content

32 result(s) found, displaying 11 to 20

Shire Australia Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use Cancelled under Section 41GL(d) of the Act

12 November 2018

Cancellation by sponsor

Requested by Shire Australia Pty Ltd
Shire Australia Pty Ltd - Medicine administration kit, percutaneous, non-medicated, single-use Cancelled under Section 41GL(d) of the Act

12 November 2018

Cancellation by sponsor

Requested by Shire Australia Pty Ltd
Shire Australia Pty Ltd - Transfer set, fluid Cancelled under Section 41GL(d) of the Act

12 November 2018

Cancellation by sponsor

Requested by Shire Australia Pty Ltd
Shire Australia Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use Cancelled under Section 41GL(d) of the Act

12 November 2018

Cancellation by sponsor

Requested by Shire Australia Pty Ltd
Shire Australia Pty Ltd - Medicine administration kit, percutaneous, non-medicated, single-use Cancelled under Section 41GL(d) of the Act

12 November 2018

Cancellation by sponsor

Requested by Shire Australia Pty Ltd
AusPAR: Lisdexamfetamine dimesilate

15 May 2018

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Lisdexamfetamine dimesilate
Shire Australia Pty Ltd - Clinical pharmacy information system Cancelled under Section 41GL(d) of the Act

28 June 2018

Cancellation by sponsor

Requested by Shire Australia Pty Ltd
RECOMBINATE octocog alfa (rch) 250IU powder for injection vial and diluent vial Cancelled under Section 30(1)(c) of the Act

26 June 2018

Cancellation by sponsor

Requested by Shire Australia Pty Ltd
RECOMBINATE octocog alfa (rch) 500IU powder for injection vial and diluent vial Cancelled under Section 30(1)(c) of the Act

26 June 2018

Cancellation by sponsor

Requested by Shire Australia Pty Ltd
RECOMBINATE octocog alfa (rch) 1000IU powder for injection vial and diluent vial Cancelled under Section 30(1)(c) of the Act

26 June 2018

Cancellation by sponsor

Requested by Shire Australia Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.